Search Results - "Patel, M.R"

Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers by Levi, M., Moore, K. T., Castillejos, C. F., Kubitza, D., Berkowitz, S. D., Goldhaber, S. Z., Raghoebar, M., Patel, M. R., Weitz, J. I., Levy, J. H.

“…Summary Background Four‐factor prothrombin complex concentrates (PCCs), which contain factor II, FVII, FIX, and FX, have shown the potential to reverse the…”
Get full text

Enhanced water loss from the martian atmosphere during a regional-scale dust storm and implications for long-term water loss by Holmes, J.A., Lewis, S.R., Patel, M.R., Chaffin, M.S., Cangi, E.M., Deighan, J., Schneider, N.M., Aoki, S., Fedorova, A.A., Kass, D.M., Vandaele, A.C.

“…•Hydrogen escape during regional dust storms on Mars display interannual variations.•Escape rate during Mars Year 34 C storm equivalent to global dust storm…”
Get full text

Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma by Krieger, D A, Hudgins, P A, Nayak, G K, Baugnon, K L, Corey, A S, Patel, M R, Beitler, J J, Saba, N F, Liu, Y, Aiken, A H

“…The Head and Neck Imaging Reporting and Data System (NI-RADS) surveillance template for head and neck cancer includes a numeric assessment of suspicion for…”
Get full text

Mud flow levitation on Mars: Insights from laboratory simulations by Brož, P., Krýza, O., Conway, S.J., Mueller, N.T., Hauber, E., Mazzini, A., Raack, J., Balme, M.R., Sylvest, M.E., Patel, M.R.

“…•Lab experiments study the behaviour of mud flows under martian atmospheric pressure.•Once the low-viscosity mud flows over a warm (∼295 K) surface, it starts…”
Get full text

Clinical Trials in Peripheral Vascular Disease Pipeline and Trial Designs: An Evaluation of the Clinical Trials.gov Database by Subherwal, S, Patel, M.R, Chiswell, K

Get full text

POS-760 Association of Vascular Endothelial Growth Factor gene polymorphism with Allograft Survival in Renal Transplant Recipients of North India by Prasad, N., Bhatt, M., Chauhan, R., Agrawal, V., Prakash, S., Patel, M.R., Agarwal, V.

Get full text

Validation of stability indicating high performance liquid chromatographic method for estimation of Desloratadine in tablet formulation by Patel, R.B., Patel, M.R., Mehta, J.B.

“…A simple, sensitive and specific stability indicating high performance liquid chromatographic (HPLC) method for the estimation of Desloratadine was developed…”
Get full text

POS-742 LONG TERM OUTCOMES OF POST-TRANSPLANT INFECTIONS IN ADULT RENAL TRANSPLANT RECIPIENTS by KUSHWAHA, R.S., Gala, R., Prasad, N., Patel, M.R., Gupta, A., Kaul, A., Bhadauria, D., Behera, M.R., Yachha, M.

Get full text

POS-470 CARDIAC BIOMARKERS AS A PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS IN THE INTENSIVE CARE UNIT by BEHERA, M.R., Prasad, N., Bhawane, A., Kaul, A., Bhadauria, D., Yachha, M., Kushwaha, R.S., Patel, M.R., Gupta, A.

Get full text

A phase 1/1b study of RXDX-105, an oral RET and BRAF inhibitor, in patients with advanced solid tumors by Drilon, A, Marwan, F, Fu, S, Patel, M.R, Olszanski, A.J, Lockhart, A.C, Liu, S.V, Bazhenova, L, Seery, T, Nikolinakos, P, Patel, R, Oliver, J.W, Multani, P.S, Wang, D

“…Background: RXDX-105 is a multikinase inhibitor that has demonstrated potent inhibition of RET and BRAF with biochemical IC50 values of 0.3-0.8 nM against RET…”
Get full text

CT Accuracy of Extrinsic Tongue Muscle Invasion in Oral Cavity Cancer by Junn, J C, Baugnon, K L, Lacayo, E A, Hudgins, P A, Patel, M R, Magliocca, K R, Corey, A S, El-Deiry, M, Wadsworth, J T, Beitler, J J, Saba, N F, Liu, Y, Aiken, A H

“…Extrinsic tongue muscle invasion in oral cavity cancer upstages the primary tumor to a T4a. Despite this American Joint Committee on Cancer staging criterion,…”
Get full text

2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation by Shapira-Frommer, R, Oza, A, Domchek, S.M, Balmana, J, Patel, M.R, Chen, L.M, Drew, Y, Burris, H.A, Korach, J, Flynn, M, Bowering, V.L, Morgan, M.A, Watkins, S.P, Simpson, D, Goble, S, Maloney, L, Kristeleit, R

Get full text

3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer by Chuong, M.D, Hayman, T.J, Patel, M.R, Russell, M.S, Malafa, M.P, Hodul, P.J, Springett, G.M, Shridhar, R, Hoffe, S.E, Choi, J

Get full text

Comparative Performance of ctHPVDNA and Imaging Surveillance for Oropharyngeal Cancer Following Radiotherapy by Ding, Y., Bates, J.E., Rudra, S., Remick, J.S., Patel, M.R., Kaka, A.S., McDonald, M.W., Stokes, W.A.

“…Imaging is routinely used in post-treatment surveillance of HPV-related oropharyngeal cancer (HPVOPC) but frequently identifies indeterminant areas of concern…”
Get full text

Instability of the continuously transposed cable under axial short-circuit forces in transformers by Patel, M.R.

“…The axial instability of the winding conductor is one of the principal modes of mechanical failure in large power transformers. It is caused by axial…”
Get full text

697P Open-label, phase I, dose escalation/expansion trial of the anti-SIRPα monoclonal antibody BI 770371 in patients with advanced solid tumours, alone or in combination with the anti-PD-1 monoclonal antibody ezabenlimab by Gutierrez, M., Jamal, R., Yamamoto, N., Doi, T., Elgadi, M., Ferrada, J.L., Wojciekowski, S.M., Patel, M.R.

Get full text

Constraints on a potential aerial biosphere on Venus: II. Ultraviolet radiation by Patel, M.R., Mason, J.P., Nordheim, T.A., Dartnell, L.R.

“…Despite the harsh conditions in the atmosphere of Venus, the possibility for an aerial habitable zone exists. A thermal habitable zone is predicted to exist at…”
Get full text

5 Oral: Preliminary Results from a Phase Ia/Ib, Open-label, Multicenter Study of ZL-1310, a DLL3-targeted ADC, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer - NCT06179069 by Spira, A., Dowlati, A., Zhao, J., Patel, M.R., Wang, Q., Dong, X., Gutierrez, M., Wang, Z., Dy, G., Liu, X., Fu, Y., Shen, X., Zhou, R., Wu, Y.L.

Get full text

Biomarker-Driven Radiation Therapy Dose Reduction after Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer by Bates, J.E., Stokes, W.A., McDonald, M.W., Rudra, S., Remick, J.S., Stallings, M.M., Saba, N.F., Schmitt, N.C., Gross, J.H., Kaka, A.S., Patel, M.R.

“…HPV-driven oropharyngeal squamous cell cancer (OPSCC) has a high cure rate and a high burden of treatment-related toxicities. Transoral robotic surgery (TORS)…”
Get full text

Factors Predictive of Primary Therapeutic Modality in Early-Stage Oropharyngeal Squamous Cell Carcinoma by Bates, J.E., Stokes, W.A., Remick, J.S., Rudra, S., McDonald, M.W., Steuer, C., Shin, D.M., Kaka, A.S., Saba, N.F., Patel, M.R.

“…Traditionally, definitive radiotherapy (RT) was the preferred treatment for oropharyngeal squamous cell carcinoma (OPSCC). Changes in both surgical technology…”
Get full text